Concourse Financial Group Securities, Inc. Neuro Pace Inc Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

18 transactions

Quarter	Operation	Price Per share
Q2 2025 Aug 12, 2025	BUY	$10.34 - $18.13 $0 - $0
Q1 2025 May 14, 2025	BUY	$10.04 - $14.94 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$5.9 - $11.93 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$6.65 - $8.46 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$6.38 - $15.33 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$9.78 - $17.5 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$5.9 - $10.31 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$4.0 - $9.73 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$4.0 - $9.73 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$3.98 - $5.12 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.44 - $5.34 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.29 - $3.67 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$3.1 - $5.98 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$4.95 - $8.7 $0 - $0
Q1 2022 May 09, 2022	BUY	$7.06 - $11.57 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$8.63 - $17.36 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$15.85 - $25.07 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$19.03 - $26.5 $0 - $0

Others Institutions Holding NPCE

# of Institutions

104

Shares Held

21.6M

Call Options Held

3.14M

Put Options Held

68.6K

Orbimed Advisors LLC San Diego, CA

2.61M
Shares

$34.7 Million
1.04% of portfolio
Morgan Stanley New York, NY

2.59M
Shares

$34.3 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

2.31M
Shares

$30.7 Million
2.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.44M
Shares

$19 Million
0.0% of portfolio
First Light Asset Management, LLC Edina, MN

1.38M
Shares

$18.3 Million
2.36% of portfolio

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $329M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account